Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
NSAID; COX-1/2 inhibitor.
Glucose metabolism inhibitor, N-linked glycosyl...
Mycotoxin, metabolite of aflatoxin B1 produced ...
Component of Frankincense resin.
Extract containing catechins and flavonoids fou...
Natriuretic, vasodilatory peptide fragment; B1/...
Triazole; 14-α demethylase inhibitor, voltage-...
Endogenous antimicrobial peptide, binds bacteri...
Endogenous sphingolipid involved in cell signal...
p110δ PI3K inhibitor.
Pan inhibitor of ALK.
Triterpene aglycone found in Radix Astragali; t...
Macrolide; protein synthesis inhibitor.
Inhibitor of tropomyosin kinase receptors TRKA,...
Diarylether; bacterial ENR binder, fatty acid s...
Synthetic peptide hormone, PTH analog; PTH1R ag...
Glutathione-S-transferase inhibitor.
Endogenous peptide, involved in water/Na+ homeo...
HDM2 inhibitor
GLP-1/GIP receptor co-agonist